DissentWatch on Nostr: Harvard Study: Half of Adult Americans Eligible for Ozempic-Like Drugs From Dr. Peter ...
Harvard Study: Half of Adult Americans Eligible for Ozempic-Like Drugs
From Dr. Peter McCullough MD
By Peter A. McCullough, MD, MPH Glucagon-like peptide receptor agonists (GLP-1 RA) are the current financial rainmakers for BIG PHARMA. Shi et al from Harvard reported recently in JAMA Cardiology. Rapidly increasing uptake of semaglutide made it the top-selling drug in the US in 2023, with net sales of $13.8 billion. Quantifying the number of […]
Nov 20th 2024 5:02am EST
Source Link: https://petermcculloughmd.substack.com/p/harvard-study-half-of-adult-americans
Share, promote & comment with Nostr: https://dissentwatch.com/boost/?boost_post_id=878237
From Dr. Peter McCullough MD
By Peter A. McCullough, MD, MPH Glucagon-like peptide receptor agonists (GLP-1 RA) are the current financial rainmakers for BIG PHARMA. Shi et al from Harvard reported recently in JAMA Cardiology. Rapidly increasing uptake of semaglutide made it the top-selling drug in the US in 2023, with net sales of $13.8 billion. Quantifying the number of […]
Nov 20th 2024 5:02am EST
Source Link: https://petermcculloughmd.substack.com/p/harvard-study-half-of-adult-americans
Share, promote & comment with Nostr: https://dissentwatch.com/boost/?boost_post_id=878237